This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

ASCP Corner

Balancing Risks: Dosing Strategies for Antidepressants Near the End of Pregnancy

Laura J. Miller, MD; Jeffrey R. Bishop, PharmD; James H. Fischer, PharmD; Stacie E. Geller, PhD; and Carol Macmillan, MD

Published: February 14, 2008

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

One of the most difficult balancing actsin clinical psychopharmacology practice isminimizing the risks of untreated depressionin pregnant women while also minimizingthe risks of antidepressant treatment.Major depression is estimated tooccur in 9.4% to 12.7% of pregnantwomen1 and to recur in over two thirds ofwomen who discontinue antidepressantmedication while pregnant.2 Antenatal depressivesymptoms can compromise outcomesfor women and their offspring.3

Volume: 69

Quick Links: Depression (MDD)

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Letter to the Editor

Stigma Kills Psychiatric Patients and Is Now Killing Clinical Research Too

Robert M. Post, MD, argues that NIMH should abandon the RDoC framework and restore funding for clinical...

Read More...